DE2901919C2 - Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des Verfahrens - Google Patents
Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des VerfahrensInfo
- Publication number
- DE2901919C2 DE2901919C2 DE2901919A DE2901919A DE2901919C2 DE 2901919 C2 DE2901919 C2 DE 2901919C2 DE 2901919 A DE2901919 A DE 2901919A DE 2901919 A DE2901919 A DE 2901919A DE 2901919 C2 DE2901919 C2 DE 2901919C2
- Authority
- DE
- Germany
- Prior art keywords
- reaction
- sample
- reagent
- measurement
- darkened
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000005259 measurement Methods 0.000 title claims description 65
- 238000006243 chemical reaction Methods 0.000 title claims description 53
- 238000000034 method Methods 0.000 title claims description 45
- 239000007788 liquid Substances 0.000 title claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 109
- 238000003860 storage Methods 0.000 claims description 14
- 210000004027 cell Anatomy 0.000 claims description 11
- 238000005415 bioluminescence Methods 0.000 claims description 10
- 230000029918 bioluminescence Effects 0.000 claims description 10
- 238000011156 evaluation Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 210000002421 cell wall Anatomy 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 4
- 241000254158 Lampyridae Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000000523 sample Substances 0.000 description 91
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 39
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 38
- 239000000126 substance Substances 0.000 description 21
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 15
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 15
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 15
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000004020 luminiscence type Methods 0.000 description 9
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 8
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 8
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 8
- 238000010791 quenching Methods 0.000 description 7
- 230000000171 quenching effect Effects 0.000 description 7
- 101100311330 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uap56 gene Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 6
- 101150018444 sub2 gene Proteins 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000005089 Luciferase Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000005375 photometry Methods 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 3
- 102000004420 Creatine Kinase Human genes 0.000 description 3
- 108010042126 Creatine kinase Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- YTNIXZGTHTVJBW-SCRDCRAPSA-N FMNH2 Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O YTNIXZGTHTVJBW-SCRDCRAPSA-N 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- -1 Molybdophosphaten Chemical compound 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- ACNUVXZPCIABEX-UHFFFAOYSA-N 3',6'-diaminospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(N)C=C1OC1=CC(N)=CC=C21 ACNUVXZPCIABEX-UHFFFAOYSA-N 0.000 description 1
- GACDQMDRPRGCTN-KQYNXXCUSA-N 3'-phospho-5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](OP(O)(O)=O)[C@H]1O GACDQMDRPRGCTN-KQYNXXCUSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- 231100000582 ATP assay Toxicity 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 102000002281 Adenylate kinase Human genes 0.000 description 1
- 108020000543 Adenylate kinase Proteins 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 240000004752 Laburnum anagyroides Species 0.000 description 1
- 241000079883 Latia Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000512292 Pholas Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241000243820 Polychaeta Species 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- GPKUGWDQUVWHIC-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine tetrahydrochloride Chemical compound Cl.Cl.Cl.Cl.NNC1=CC=C(C=C1)C1=CC=C(NN)C=C1 GPKUGWDQUVWHIC-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000003922 bacterial chromatophore Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000003567 photophosphorylation Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plasma & Fusion (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2901919A DE2901919C2 (de) | 1979-01-18 | 1979-01-18 | Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des Verfahrens |
| US06/111,000 US4390274A (en) | 1979-01-18 | 1980-01-10 | Use of a method, particularly an automatic method, for measuring light as well as improvements and apparatuses for carrying out the same |
| GB8001561A GB2045929B (en) | 1979-01-18 | 1980-01-17 | Photometric analysis of a succession of samples adding reagents in situ |
| FR8001037A FR2447028A1 (fr) | 1979-01-18 | 1980-01-18 | Procede (notamment automatique) de photometrie, applications de ce procede et appareil pour sa mise en oeuvre |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2901919A DE2901919C2 (de) | 1979-01-18 | 1979-01-18 | Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des Verfahrens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2901919A1 DE2901919A1 (de) | 1980-07-24 |
| DE2901919C2 true DE2901919C2 (de) | 1987-04-02 |
Family
ID=6060882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2901919A Expired DE2901919C2 (de) | 1979-01-18 | 1979-01-18 | Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des Verfahrens |
Country Status (4)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008011013A1 (de) * | 2008-02-25 | 2009-09-03 | Labo Tech Labortechnik Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3239866A1 (de) * | 1982-10-27 | 1984-05-03 | Laboratorium Prof. Dr. Rudolf Berthold, 7547 Wildbad | Abdunkelbare messstation eines photometers |
| DE8230199U1 (de) * | 1982-10-27 | 1983-03-24 | Laboratorium Prof. Dr. Rudolf Berthold, 7547 Wildbad | Abdunkelbare messstation eines photometers |
| SE8307024L (sv) * | 1983-12-19 | 1985-06-20 | Wallac Oy | Sett och anordning for luminiscensmetning |
| US5591581A (en) * | 1986-04-30 | 1997-01-07 | Igen, Inc. | Electrochemiluminescent rhenium moieties and methods for their use |
| DE4123818C2 (de) * | 1991-07-18 | 1994-05-19 | Berthold Lab Prof Dr | Vorrichtung zur Messung der Chemilumineszenz einer in einem Probengefäß befindlichen Probe |
| US5395752A (en) * | 1993-03-19 | 1995-03-07 | Ciba Corning Diagnostics Corp. | Long emission wavelength chemiluminescent compounds and their use in test assays |
| AU687363B2 (en) * | 1993-03-19 | 1998-02-26 | Ciba Corning Diagnostics Corp. | Luminometer |
| US5744320A (en) * | 1995-06-07 | 1998-04-28 | Promega Corporation | Quenching reagents and assays for enzyme-mediated luminescence |
| US5686046A (en) * | 1995-07-13 | 1997-11-11 | Chiron Diagnostics Corporation | Luminometer |
| US5798263A (en) * | 1996-09-05 | 1998-08-25 | Promega Corporation | Apparatus for quantifying dual-luminescent reporter assays |
| JP2995205B1 (ja) * | 1998-08-04 | 1999-12-27 | 農林水産省家畜衛生試験場長 | 乳房炎診断装置 |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| JP5155515B2 (ja) * | 2002-09-06 | 2013-03-06 | プロメガ コーポレイション | トランスフェラーゼ酵素活性を検出する方法 |
| EP2325329B1 (en) | 2002-12-23 | 2014-02-12 | Promega Corporation | Improved luciferase-based assays |
| US20040224377A1 (en) * | 2003-02-12 | 2004-11-11 | Erika Hawkins | Compositions and methods to quench light from optical reactions |
| US20100129840A1 (en) * | 2006-10-13 | 2010-05-27 | Charm Scineces, Inc | Method and Apparatus for Reducing Luminescent Test Result Interferences |
| WO2008118445A1 (en) * | 2007-03-26 | 2008-10-02 | Promega Corporation | Methods to quench light from optical reactions |
| GB2448499B (en) * | 2007-04-17 | 2011-03-23 | Krysium Advisors Ltd | Method of testing an organic sample |
| US10619182B2 (en) | 2014-12-26 | 2020-04-14 | Hitachi, Ltd. | Method, device and system for testing drug sensitivity |
| JP6722751B2 (ja) * | 2018-12-21 | 2020-07-15 | 株式会社日立製作所 | 薬剤感受性試験システム |
| US20220162697A1 (en) * | 2019-05-17 | 2022-05-26 | Creoptix Ag | Methods for determining kinetic parameters of a reaction between analyte and ligands |
| CN117849015B (zh) * | 2024-03-04 | 2024-05-10 | 臻萃(江苏)酶科技发展有限公司 | 一种尿酸检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3542515A (en) * | 1968-08-06 | 1970-11-24 | Perkin Elmer Corp | Determining reaction rates by simultaneous two-point measurements |
| US3797999A (en) * | 1970-05-20 | 1974-03-19 | Aerojet General Co | Method and apparatus for indicating micro-organic matter by means of chemiluminescence |
| US3745090A (en) * | 1970-08-04 | 1973-07-10 | Nasa | Method of detecting and counting bacteria in body fluids |
| US3719410A (en) * | 1971-11-10 | 1973-03-06 | Farrand Optical Co Inc | Mixing and measuring apparatus |
| DE2219552A1 (de) * | 1972-04-21 | 1973-11-08 | Bodenseewerk Perkin Elmer Co | Photometrisches analysenverfahren |
| US3841765A (en) * | 1973-05-17 | 1974-10-15 | Univ Kansas State | Microdiffusion cell |
| US3869215A (en) * | 1974-02-22 | 1975-03-04 | Instrumentation Labor Inc | Sample cell assembly having a heat conductive chamber surrounded by an electrothermal heating layer |
| US3882028A (en) * | 1974-05-17 | 1975-05-06 | Thermo Electron Corp | Multiple chamber chemiluminescent analyzer |
| US4058732A (en) * | 1975-06-30 | 1977-11-15 | Analytical Radiation Corporation | Method and apparatus for improved analytical fluorescent spectroscopy |
| US4101276A (en) * | 1976-06-02 | 1978-07-18 | Beckman Instruments, Inc. | Method and apparatus for signalling the introduction of chemical reaction components into a chemical analyzing system |
| DE2804881C3 (de) * | 1978-02-04 | 1980-08-07 | Fa. Carl Zeiss, 7920 Heidenheim | Gerät zur automatischen Analyse von flüssigen Proben |
-
1979
- 1979-01-18 DE DE2901919A patent/DE2901919C2/de not_active Expired
-
1980
- 1980-01-10 US US06/111,000 patent/US4390274A/en not_active Expired - Lifetime
- 1980-01-17 GB GB8001561A patent/GB2045929B/en not_active Expired
- 1980-01-18 FR FR8001037A patent/FR2447028A1/fr active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008011013A1 (de) * | 2008-02-25 | 2009-09-03 | Labo Tech Labortechnik Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
| DE102008011013B4 (de) * | 2008-02-25 | 2014-11-13 | Mevitec Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2045929B (en) | 1983-08-17 |
| DE2901919A1 (de) | 1980-07-24 |
| FR2447028A1 (fr) | 1980-08-14 |
| FR2447028B1 (US20030199744A1-20031023-C00003.png) | 1984-02-17 |
| US4390274A (en) | 1983-06-28 |
| GB2045929A (en) | 1980-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2901919C2 (de) | Verfahren zur photometrischen Reihenmessung an Reaktionsvorgängen in flüssigen Proben und Vorrichtung zur Durchführung des Verfahrens | |
| DE3115600C2 (de) | Verfahren und Vorrichtung zum automatischen Analysieren chemischer Substanzen in flüssigen Proben | |
| DE68907344T2 (de) | Verfahren und Vorrichtung zur Anzeige von Urinbestandteilen. | |
| DE69008857T2 (de) | Verfahren und vorrichtung zur quantitativen anzeige einer in einem flüssigen medium gelösten chemischen komponente. | |
| DE2649548C3 (de) | Photometrisches Analysengerät | |
| DE102011007011B4 (de) | Analysegerät zur automatisierten Bestimmung einer Messgröße einer Flüssigkeitsprobe und Verfahren zur Überwachung einer Messgröße | |
| DE2228668A1 (de) | Verfahren und Vorrichtung zur quanti tativen Bestimmung eines in einer Fluid probe enthaltenen Bestandteils | |
| DE2128793A1 (de) | Einrichtung für chemische Analysen. | |
| DE69506394T2 (de) | Verfahren zum kalibrieren chemischer tests | |
| DE2219552A1 (de) | Photometrisches analysenverfahren | |
| DE2804657A1 (de) | Verfahren und vorrichtung zur durchfuehrung von immuntests | |
| DE1811788A1 (de) | Vorrichtung zur automatischen Durchfuehrung von Fluessigkeitsanalysen | |
| EP1411346B1 (de) | Verfahren zur Erkennung und Kompensation der Unterdosierung von Teststreifen | |
| DE2144136A1 (de) | Mittel und verfahren zur bestimmung von calcium | |
| EP0154152B1 (de) | Verfahren und Mittel zur Bestimmung von Nitrationen | |
| DE2530036A1 (de) | Verfahren zur bestimmung von harnstoff in fluessigkeiten | |
| DE102015119608A1 (de) | Automatisches Analysegerät und Verfahren | |
| DE2450609A1 (de) | Vorrichtung zur automatischen bestimmung von proteinen | |
| EP0825264B1 (de) | Stabile Mischung zum Nachweis alkalischer Phosphatase mit einem Salz der o-Kresolphthaleinmonophosphorsäure | |
| DE102020129213A1 (de) | Verfahren zum Kalibrieren eines photometrischen Analysators | |
| DE69016872T2 (de) | Verfahren zur Messung eines Bestandteiles in einer Flüssigkeit. | |
| DE2341158B2 (de) | Automatisches Analysiergerät für fließfähige Proben, insbesondere für klinische und pharmazeutische Zwecke | |
| EP0340511A1 (de) | Trägergebundenes mehrkomponentiges Nachweissystem zur kolorimetrischen Bestimmung esterolytisch oder/und proteolytisch aktiver Inhaltsstoffe von Körperflüssigkeiten | |
| DE2130340C3 (de) | Verfahren und Vorrichtung zur quantitativen Bestimmung von einzelnen Proben unterschiedlicher Konzentration von Substanzen | |
| DE19712214C2 (de) | Optisches Meßverfahren zur Bestimmung der Bio- oder Chemolumineszenz einer Probe, insbesondere im Rahmen des Leuchtbakterientests, und Vorrichtung zur Durchführung des Verfahrens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OAP | Request for examination filed | ||
| OD | Request for examination | ||
| 8127 | New person/name/address of the applicant |
Owner name: LUMAC INTERNATIONAL N.V., WILLEMSTAD, CURACAO, NL |
|
| 8128 | New person/name/address of the agent |
Representative=s name: REDIES, F., DR.-ING. DR.JUR. REDIES, B., DIPL.-CHE |
|
| 8128 | New person/name/address of the agent |
Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI |
|
| 8128 | New person/name/address of the agent |
Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI |
|
| 8127 | New person/name/address of the applicant |
Owner name: MINNESOTA MINING AND MANUFACTURING CO., SAINT PAUL |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |